Italia markets open in 6 hours 57 minutes

PFE Nov 2024 29.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,0900-0,0100 (-0,91%)
In data: 03:52PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,1000
Aperto1,1300
Denaro1,1300
Domanda1,1600
Prezzo d'esercizio29,00
Scadenza2024-11-15
Min-Max giorno1,0400 - 1,1900
Contratto - Min-MaxN/D
Volume207
Open Interest8,52k
  • GlobeNewswire

    Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentation at ESMO Congress 2023

    NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will present updated Phase 1/2 data for vepdegestrant (ARV-471) at the 2023 European Society for Medical Oncology (ESMO) Annual Congress. Vepdegestrant is a novel oral PROTAC® estrogen receptor (ER) degrader that is being jointly developed by Arvinas and Pfizer for the treatment of patients with locally advanced or metastatic ER positive/human epidermal g